Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
Clinical trial NCT06877416 · RECRUITING
Trial details
- NCT number
- NCT06877416
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.